These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6116543)

  • 1. [Comparison of the effects of prazosin and phenoxybenzamine on arterial pressure, heart rate and plasma catecolamines in essential arterial hypertension].
    Mulvihill-Wilson J; Graham RM; Pettinger WA; Muckleroy C; Anderson S; Gaffney F; Blomqvist CG
    Cardiology; 1980; 66 Suppl 2():85-93. PubMed ID: 6116543
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension.
    Mulvihill-Wilson J; Graham RM; Pettinger W; Muckleroy C; Anderson S; Gaffney FA; Blomqvist CG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S1-7. PubMed ID: 94635
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.
    Mulvihill-Wilson J; Gaffney FA; Pettinger WA; Blomqvist CG; Anderson S; Graham RM
    Circulation; 1983 Feb; 67(2):383-93. PubMed ID: 6129077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes.
    Atkins FL; Nicolosi GL
    Biochem Pharmacol; 1979 Apr; 28(7):1233-7. PubMed ID: 36093
    [No Abstract]   [Full Text] [Related]  

  • 5. Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in non-sedated male beagle dogs.
    Fischer JR; Lane IF; Cribb AE
    Can J Vet Res; 2003 Jan; 67(1):30-8. PubMed ID: 12528826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha adrenergic blockade by prazosin in therapy of essential hypertension.
    Ram CV; Anderson RJ; Hart GR; Crumpler CP
    Clin Pharmacol Ther; 1981 Jun; 29(6):719-22. PubMed ID: 6112091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of antihypertensive drugs with special reference to vasodilators, alpha-adrenergic blocking agents and prazosin.
    Cambridge D; Davey MJ; Massingham R
    Med J Aust; 1977 Aug; 2(1 Suppl):2-6. PubMed ID: 21341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in blood viscosity concomitant with prazosin therapy in patients with essential arterial hypertension].
    Letcher RL; Chien S; Laragh JG
    Cardiology; 1980; 66 Suppl 2():12-25. PubMed ID: 6269739
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating beta adrenergic stimulator during elevated cerebrospinal fluid pressure.
    Brashear RE; Ross JC
    Arch Intern Med; 1971 Apr; 127(4):748-53. PubMed ID: 4396673
    [No Abstract]   [Full Text] [Related]  

  • 11. Prazosin and phentolamine: comparative cardiovascular and autonomic profiles.
    Commarato MA; Langley AE; Dugan DH; Lattime EC; Smith RD; Tessman DK; Kaplan HR
    Clin Exp Hypertens (1978); 1978; 1(2):191-217. PubMed ID: 39713
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of prazosin and clonidine on sympathetic and baroreflex function in patients with essential hypertension.
    Guthrie GP; Kotchen TA
    J Clin Pharmacol; 1983; 23(8-9):348-54. PubMed ID: 6630584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension.
    Ikeda T; Nonaka Y; Goto A; Ishii M
    Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
    Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA
    Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic mechanisms opposing the hemodynamic effects of prazosin.
    Izzo JL; Horwitz D; Keiser HR
    Clin Pharmacol Ther; 1981 Jan; 29(1):7-11. PubMed ID: 7460477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of prazosin.
    Barbieri C; Caldara R; Ferrari C; Dal Bo GA; Paracchi A; Romussi M; Curtarelli G
    Clin Pharmacol Ther; 1980 Mar; 27(3):313-6. PubMed ID: 6102000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities.
    Timmermans PB; Kwa HY; Ali FK; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):218-35. PubMed ID: 6105854
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled prazosin in asthma.
    Barnes PJ; Ind PW; Dollery CT
    Thorax; 1981 May; 36(5):378-81. PubMed ID: 6118964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced blood pressure response to isometric handgrip exercise in patients with essential hypertension: effects of propranolol and prazosin.
    Hamada M; Kazatani Y; Shigematsu Y; Ito T; Kokubu T; Ishise S
    J Hypertens; 1987 Jun; 5(3):305-9. PubMed ID: 3302040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.